3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Dosing strategy in patients with renal failure receiving enoxaparin for the treatment of non-ST-segment elevation acute coronary syndrome

      , , , , ,
      Clinical Pharmacology & Therapeutics
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Enoxaparin therapy is recommended for the initial treatment of patients with non-ST-segment elevation acute coronary syndrome. However, little dosing information is available regarding the use of enoxaparin in patients with renal impairment.

          Related collections

          Author and article information

          Journal
          Clinical Pharmacology & Therapeutics
          Clinical Pharmacology & Therapeutics
          Elsevier BV
          00099236
          June 2005
          June 2005
          : 77
          : 6
          : 542-552
          Article
          10.1016/j.clpt.2005.02.012
          15961985
          ba274e66-5c3f-4a3c-9a6f-59128768aa6a
          © 2005
          History

          Comments

          Comment on this article